I’m guessing it’s just an assumption based on the recent PRs and events. The company has been very quiet, November has passed, Christmas is only three weeks away, and nothing is guaranteed. My real concern is that if we don’t receive approval before Christmas, we might not get it anytime soon—and I don’t even want to think about that. Six months ago, when the MHRA modified the XL designation by changing ‘GBM’ to all cancers or something similar, an investor here said approval was a done deal and could come any day. It’s now been over six months, and there’s still no approval.
Market Data 
Markets 
AI
